Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 2—February 2022
Research Letter

Surveillance of Rodent Pests for SARS-CoV-2 and Other Coronaviruses, Hong Kong

Elliott F. Miot1, Brian M. Worthington1, Kar Hon Ng1, Lucy de Guilhem de Lataillade1, Mac P. Pierce, Yunshi Liao, Ronald Ko, Marcus H. Shum, William Y. Cheung, Edward C. Holmes, Kathy S. Leung, Huachen Zhu, Leo L. Poon, Malik J. Peiris, Yi Guan, Gabriel M. Leung, Joseph T. WuComments to Author , and Tommy T. LamComments to Author 
Author affiliations: University of Hong Kong State Key Laboratory of Emerging Infectious Diseases, Hong Kong, China (E.F. Miot, B.M. Worthington, K.H. Ng, L. de Guilhem de Lataillade, M.P. Pierce, Y. Liao, M.H. Shum, W.Y. Cheung, H. Zhu, Y. Guan, T.T. Lam); University of Hong Kong School of Public Health, Hong Kong (E.F. Miot, B.M. Worthington, K.H. Ng, L. de Guilhem de Lataillade, M.P. Pierce, Y. Liao, R. Ko, M.H. Shum, W.Y. Cheung, H. Zhu, L.L. Poon, M.J. Peiris, Y. Guan, G.M. Leung, J.T. Wu, T.T. Lam); University of Hong Kong HKU-Pasteur Research Pole, Hong Kong (E.F. Miot, L. de Guilhem de Lataillade, L.L. Poon, M.J. Peiris); Centre for Immunology & Infection Limited, Hong Kong (E.F. Miot, L. de Guilhem de Lataillade, L.L. Poon, M.J. Peiris, T.T. Lam); Shantou University/University of Hong Kong Guangdong-Hongkong Joint Laboratory of Emerging Infectious Diseases, Shantou, Guangdong, China. (B.M. Worthington, W.Y. Cheung, H. Zhu, Y. Guan, T.T. Lam); EKIH (Gewuzhikang) Pathogen Research Institute, Shenzhen City, Guangdong, China. (B.M. Worthington, W.Y. Cheung, H. Zhu, Y. Guan, T.T. Lam); Laboratory of Data Discovery for Health Limited, Hong Kong, China (W.Y. Cheung, E.C. Holmes, K.S. Leung, H. Zhu, Y. Guan, G.M. Leung, J.T. Wu, T.T. Lam); Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney School of Biological Sciences, and Sydney Medical School, Sydney, New South Wales, Australia (E.C. Holmes)

Cite This Article


We report surveillance conducted in 217 pestiferous rodents in Hong Kong for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We did not detect SARS-CoV-2 RNA but identified 1 seropositive rodent, suggesting exposure to a virus antigenically similar to SARS-CoV-2. Potential exposure of urban rodents to SARS-CoV-2 cannot be ruled out.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in Wuhan, China, in late 2019 (1) and soon spread globally. Although its zoonotic origin remains unclear, animal species potentially susceptible to reverse-zoonotic transmission from humans have been identified (e.g., cats, dogs, minks, deer), some of which (e.g., mink) might maintain the virus and pose a risk of future spillback to humans (2,3). Domestic animals and urban wildlife are of particular concern (4) because of their potential exposure to viruses shed within urban environments. Analysis of the angiotensin-converting enzyme 2 (ACE2) receptor across diverse vertebrates suggests a potentially wide breadth of SARS-CoV-2–susceptible mammal host species (5).

The rapid transmission and adaptation of SARS-CoV-2 in humans has been characterized by the evolution of variants of concern (VOCs). Several VOCs, particularly the Alpha (B.1.1.7), Beta (B.1.351), and Gamma (P.1) variants, have convergently evolved an amino acid residue change in the receptor binding domain of the spike protein (N501Y) that was also observed following serial passage of SARS-CoV-2 in BALB/c mice (6). Recent in vitro and in vivo experiments have demonstrated that these VOCs are capable of infecting laboratory rats and mice (7; Montagutelli X et al., unpub. data, Such evolutionary processes indicate a possible risk for reverse-zoonotic transmission of VOCs into urban rodents.

We hypothesized that locations with positive SARS-CoV-2 detection in sewage could also serve as key surveillance targets for potential exposure of pestiferous urban rodents to SARS-CoV-2 shed into the environment. We conducted sewage surveillance in Hong Kong to identify hidden infections and localized outbreaks of SARS-CoV-2 (8) during the fourth wave of COVID-19 in Hong Kong (Appendix).


Surveillance of rodents for SARS-COV-2 conducted February–May 2021 in Hong Kong. A) Sampling sites, with number of rodents sampled and sewage testing positive for SARS-COV-2. Each circle represents a sampling location, color-coded by district and sized proportional to the number of captured rodents. Blue crosses represent locations where sewage was reported positive for SARS-COV-2during January 19–March 30, 2021. B) Number of sampled rodents, by collection dates and district. SARS-COV-2, severe acute respiratory syndrome coronavirus 2

Figure. Surveillance of rodents for SARS-COV-2 conducted February–May 2021 in Hong Kong. A) Sampling sites, with number of rodents sampled and sewage testing positive for SARS-COV-2. Each circle represents a sampling...

During February 3–May 12, 2021, we sampled 217 rodents (Rattus spp.), 193 live-trapped rodents and 24 found dead near collection sites (Appendix Table 1). We collected 189 R. norvegicus and 28 R. tanezumi rats from 8 districts, the majority (n = 186) from Sham Shui Po, Yau Tsim Mong, and Kowloon City (Figure), where SARS-CoV-2 positive sewage has been reported.

We found samples from 1,702 swabs and tissues from 217 rats negative for SARS-CoV-2 by real-time quantitative PCR and 15 from 9 rats positive for murine alphacoronaviruses and betacoronaviruses using PCR and phylogenetic analysis (Appendix Table 2, Figure 1). Using ELISA, we identified 1 of 213 rodent serum samples from an R. norvegicus rat collected in Yau Ma Tei seropositive for SARS-CoV-2 (Table; Appendix Figure 2) and 11 samples inconclusive; only 1 of 2 replicates from 8 samples gave a positive absorbance result, and 1 or both replicates from 3 samples gave a borderline absorbance (Table; Appendix Figure 2). The unambiguously positive sample, from rat no. 213, was confirmed positive in surrogate virus neutralization testing (sVNT; 31.7% inhibition), but negative by plaque-reduction neutralization test (PRNT90; <10 titers for 90% reduction). All 11 inconclusive samples were negative (<20% inhibition) by sVNT. As a pre–COVID-19 biological control to test for cross-sensitivity, 50 rodent serum samples collected in 2008 were examined by ELISA; none exhibited an unambiguously positive result.

Our rodent surveillance in Hong Kong revealed potential exposure to SARS-CoV-2, and although viral RNA was not detected, this could be a limitation of sample size if prevalence of active infection was low. One serum sample showed positive ELISA and sVNT results but negative PRNT90 results. Previous research demonstrated that the sVNT used in our study has >98.8% specificity and sensitivity without cross-reaction to alphacoronaviruses and murine betacoronavirus (9). Some sVNT-positive COVID-19–confirmed patients did not meet the threshold for positivity by PRNT90 (9). This finding suggests that the seropositive result for SARS-CoV-2 or a closely related virus in the brown rat was unlikely to be attributable to past exposure to murine alphacoronaviruses or betacoronaviruses.

During our study period, SARS-CoV-2 infection was reported in several imported and local human cases in multiple locations and in multiple sewage results. Before December 2020, SARS-CoV-2 locally circulating in Hong Kong predominantly carried 501N with presumably lower rodent infectivity; however, during our study period, Hong Kong reported many imported cases of SARS-CoV-2 variants, including B.1.1.7 and B.1.351, carrying 501Y, which has been demonstrated in mouse experiments to be a critical genetic adaptation (6). These imported cases might disseminate virus into the environment near quarantine hotels, presenting an increased risk of spillover into urban rodent populations and requiring enhanced biosecurity to limit potential exposure to urban rodents or other susceptible animals. Our finding of potential SARS-CoV-2 exposure in a pestiferous rat highlights the need for sustained monitoring of rodent populations to rapidly detect spillover events and subsequently put in place timely interventions (e.g., disinfestation using trapping and pesticide) to prevent potential establishment of new reservoirs.

Dr. Miot is a postdoctoral researcher at the Centre for Immunology and Infection, HKU-Pasteur Research Pole, State Key Laboratory of Emerging Infectious Diseases, and University of Hong Kong School of Public Health. His research interest is vectorborne diseases.



We gratefully thank M.W. Lee, S.K. Hung, S.T. Lui, P.H. Yuen, and other staff from the Food and Environmental Hygiene Department who provided assistance with trapping and euthanizing rodents.

This work was supported by National Science Foundation of China Excellent Young Scientists Fund (Hong Kong and Macau) (31922087), Guangdong-Hong Kong-Macau Joint Laboratory Program (2019B121205009), National Key R&D Program of China (2017YFE0190800), and US National Institute of Allergy and Infectious Diseases (U01AI151810).



  1. Wu  F, Zhao  S, Yu  B, Chen  YM, Wang  W, Song  ZG, et al. A new coronavirus associated with human respiratory disease in China. [Correction in Nature. 2020;580:E7]. Nature. 2020;579:2659. DOIPubMedGoogle Scholar
  2. Chandler  JC, Bevins  SN, Ellis  JW, Linder  TJ, Tell  RM, Jenkins-Moore  M, et al. SARS-CoV-2 exposure in wild white-tailed deer (Odocoileus virginianus). Proc Natl Acad Sci U S A. 2021;118:e2114828118. DOIPubMedGoogle Scholar
  3. Oude Munnink  BB, Sikkema  RS, Nieuwenhuijse  DF, Molenaar  RJ, Munger  E, Molenkamp  R, et al. Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans. Science. 2021;371:1727. DOIPubMedGoogle Scholar
  4. Bosco-Lauth  AM, Root  JJ, Porter  SM, Walker  AE, Guilbert  L, Hawvermale  D, et al. Peridomestic mammal susceptibility to severe acute respiratory syndrome coronavirus 2 infection. Emerg Infect Dis. 2021;27:207380. DOIPubMedGoogle Scholar
  5. Damas  J, Hughes  GM, Keough  KC, Painter  CA, Persky  NS, Corbo  M, et al. Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates. Proc Natl Acad Sci U S A. 2020;117:2231122. DOIPubMedGoogle Scholar
  6. Gu  H, Chen  Q, Yang  G, He  L, Fan  H, Deng  YQ, et al. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy. Science. 2020;369:16037. DOIPubMedGoogle Scholar
  7. Shuai  H, Chan  JF, Yuen  TT, Yoon  C, Hu  JC, Wen  L, et al. Emerging SARS-CoV-2 variants expand species tropism to murines. EBioMedicine. 2021;73:103643. DOIPubMedGoogle Scholar
  8. Xu  X, Zheng  X, Li  S, Lam  NS, Wang  Y, Chu  DKW, et al. The first case study of wastewater-based epidemiology of COVID-19 in Hong Kong. Sci Total Environ. 2021;790:148000. DOIPubMedGoogle Scholar
  9. Perera  RAPM, Ko  R, Tsang  OTY, Hui  DSC, Kwan  MYM, Brackman  CJ, et al. Evaluation of a SARS-CoV-2 surrogate virus neutralization test for detection of antibody in human, canine, cat, and hamster sera. J Clin Microbiol. 2021;59:e0250420. DOIPubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid2802.211586

Original Publication Date: January 13, 2022

1These coauthors contributed equally to this article.

Table of Contents – Volume 28, Number 2—February 2022

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Joseph Tsz-Kei Wu, School of Public Health, University of Hong Kong, 7 Sassoon Road, Pokfulam, Hong Kong, China

Send To

10000 character(s) remaining.


Page created: November 11, 2021
Page updated: January 22, 2022
Page reviewed: January 22, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.